In summary, we showed that FTO and ALKBH5 are differentially expressed among different RCC subtypes and oncocytomas, eventually proving useful for discrimination between malignant and benign renal cell tumors, as well as for prognostic assessment. Here, FTO is linked to renal cell carcinoma.